Home › Funds › Vivo Capital, LLC › ANTX

Vivo Capital, LLC position in ANTX

AN2 THERAPEUTICS INC · Health Care

Vivo Capital, LLC reported holding 3,153,640 shares of ANTX (AN2 THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$16.8M, representing 1.90% of its reported portfolio and ranking #20 among its reported holdings. Vivo Capital, LLC has disclosed ANTX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)3.15M sh
Reported value held$16.78M
Portfolio Weight1.90%
First reportedQ1 2026
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Vivo Capital, LLC's ANTX position evolved

Vivo Capital, LLC first disclosed a stake in ANTX in Q1 2026 at 3,153,640 shares (US$10.8M). The position peaked in Q3 2026 at 3,153,640 shares, worth US$16.8M. Across 3 filings, Vivo Capital, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 3,153,640 shares valued at US$16.8M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 3.15M $10.79M New
Q2 2026 3.15M $15.26M Hold
Q3 2026 3.15M $16.78M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANTX and 13F data

ANTX (AN2 THERAPEUTICS INC) is a Health Care company. 44 other funds we track also report a position in ANTX — the largest reported positions include Commodore Capital LP (US$14.2M), Spruce Street Capital LP (US$8.0M), Almitas Capital LLC (US$7.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANTX

All ANTX fund holders →

FAQ

How long has Vivo Capital, LLC held ANTX?

Vivo Capital, LLC has disclosed ANTX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Vivo Capital, LLC's current position in ANTX?

As of Q3 2026, Vivo Capital, LLC holds 3.15M shares of ANTX (AN2 THERAPEUTICS INC), valued at $16.78M, representing 1.90% of its reported portfolio and ranking #20.

Has Vivo Capital, LLC been buying or selling ANTX?

In the latest 13F filing (Q3 2026), Vivo Capital, LLC held unchanged its position in ANTX. The position peaked in Q3 2026 at 3.15M shares.

Which other funds hold ANTX?

Other major institutional holders of ANTX include Commodore Capital LP, Spruce Street Capital LP, Almitas Capital LLC, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.